miR-888: A Novel Cancer-Testis Antigen that Targets the Progesterone Receptor in Endometrial Cancer

miR-888: A Novel Cancer-Testis Antigen that Targets the Progesterone Receptor in Endometrial Cancer

Cancer-testis (CT) antigens are a large family of genes that are selectively expressed in human testis germ cells, overexpressed in a variety of tumors and predominantly located on the X chromosome. To date, all known CT antigens are protein-coding genes. Here, we identify miR-888 as the first miRNA...

Full description

Bibliographic Details
Main Authors:	Adriann M. Hovey, Eric J. Devor, Patrick J. Breheny, Sarah L. Mott, Donghai Dai, Kristina W. Thiel, Kimberly K. Leslie
Format:	Article
Language:	English
Published:	Elsevier 2015-04-01
Series:	Translational Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523315000054

Similar Items

Characterization of miR-888 expression and regulation in endometrial cancer
by: Hovey, Adriann Marie
Published: (2014)

Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer.
by: Tamar Kavlashvili, et al.
Published: (2016-01-01)

Cancer-Testis Antigen Expression in Serous Endometrial Cancer with Loss of X Chromosome Inactivation.
by: Jun Kang, et al.
Published: (2015-01-01)

Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
by: Paul H van der Horst, et al.
Published: (2012-01-01)

CANCER TESTIS ANTIGENS IN CANCER IMMUNOTHERAPY
by: D. I. Vodolazhsky, et al.
Published: (2017-06-01)

Cancer testis antigen and immunotherapy
by: Krishnadas DK, et al.
Published: (2013-04-01)

Cancer/testis antigens (CTAs) expression in resected lung cancer
by: Jin S, et al.
Published: (2018-08-01)

Targeting cancer testis antigens in synovial sarcoma
by: Geoffrey Mitchell, et al.
Published: (2021-06-01)

YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer
by: Izumi Suzuki, et al.
Published: (2021-02-01)

Characterization of the cancer/testis antigen CABYR
by: Yen-Tzu Tseng, et al.
Published: (2011)

Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
by: Uwe Schirmer, et al.
Published: (2018-10-01)

The Oncoplacental Gene Placenta-Specific Protein 1 Is Highly Expressed in Endometrial Tumors and Cell Lines
by: Eric J. Devor, et al.
Published: (2013-01-01)

Frequency of cancer testis antigens in chronic myeloid leukemia
by: I. Mendoza-Salas, et al.
Published: (2016-04-01)

Identification of novel human cancer-testis-antigen genes in cancers
by: Almutairi, Mikhlid Hammad
Published: (2014)

Comprehensive bioinformatics analysis of acquired progesterone resistance in endometrial cancer cell line
by: Wenzhi Li, et al.
Published: (2019-02-01)

Correlation of estrogen and progesterone receptors ER and PR expression with the growth of endometrial cancer
by: Xiang-Zhuan Gao, et al.
Published: (2017-07-01)

An integrated prediction model of recurrence in endometrial endometrioid cancers
by: Miller MD, et al.
Published: (2019-06-01)

Cancer Testis Antigens and Immunotherapy: A new Dawn
by: Zhang Bingcan
Published: (2021-01-01)

CAR T-Cell Cancer Therapy Targeting Surface Cancer/Testis Antigens
by: Mie K. Jakobsen, et al.
Published: (2020-09-01)

Cancer/testis antigens and obligate participation in multiple hallmarks of cancer: an update
by: Steven M Mooney, et al.
Published: (2016-01-01)

Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
by: Kaipeng Xie, et al.
Published: (2019-01-01)

Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects
by: Xiao Wei, et al.
Published: (2019-05-01)

Identification and characterisation of novel cancer testis antigens in human cancer cells
by: Alsiwiehri, Naif O.
Published: (2017)

Researches on the Correlation Between Estrogen and Progesterone Receptors Expression and Disease-Free Survival of Endometrial Cancer
by: Ren S, et al.
Published: (2020-12-01)

Progesterone control of human endometrial cells
by: Dunn, C. L.
Published: (2003)

Past, present, and future of hormonal therapy in recurrent endometrial cancer
by: Carlson MJ, et al.
Published: (2014-05-01)

Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro
by: Ana Paucarmayta, et al.
Published: (2020-03-01)

Cancer Testis Antigen, NOL4, Is an Immunogenic Antigen Specifically Expressed in Small-Cell Lung Cancer
by: Ye-Rin Kim, et al.
Published: (2021-05-01)

Characterization of cancer/testis antigen MAGE-A11 for immunotherapy of prostate cancer
by: Dadvar, Ehsan
Published: (2014)

Expression of Cancer Testis Antigens in Colorectal Cancer: New Prognostic and Therapeutic Implications
by: Maciej Tarnowski, et al.
Published: (2016-01-01)

Cancer/Testis Antigens: “Smart” Biomarkers for Diagnosis and Prognosis of Prostate and Other Cancers
by: Prakash Kulkarni, et al.
Published: (2017-03-01)

Targeting Wnt Signaling in Endometrial Cancer
by: Iram Fatima, et al.
Published: (2021-05-01)

The Novelty of Human Cancer/Testis Antigen Encoding Genes in Evolution
by: Pavel Dobrynin, et al.
Published: (2013-01-01)

Integrative discovery of epigenetically derepressed cancer testis antigens in NSCLC.
by: Chad A Glazer, et al.
Published: (2009-12-01)

Expression of cancer testis antigens in patients with Hodgkin's lymphoma and their clinical correlation
by: L.M. Hodgson Reyes, et al.
Published: (2018-01-01)

Prognostic significance of miR-205 in endometrial cancer.
by: Mihriban Karaayvaz, et al.
Published: (2012-01-01)

The Empire that was always Decaying: The Carolingians (800-888)
by: Mayke de Jong
Published: (2015-01-01)

The reign of Charles III the Fat (876-888)
by: Maclean, Simon
Published: (2000)

A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables
by: Erin A. Salinas, et al.
Published: (2019-03-01)

64 Cancer testis antigen co-expression landscape in solid tumors
by: Sean Glenn, et al.
Published: (2020-11-01)